1
2
van der Pol, Simon, Degener, Fabian, Postma, Maarten J., Vemer, Pepijn
Veröffentlicht in: van der Pol , S , Degener , F , Postma , M J & Vemer , P 2017 , ' An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands ' , Value in Health , vol. 20 , no. 3 , pp. 388-396 . https://doi.org/10.1016/j.jval.2016.10.015;
2017
Veröffentlicht in: van der Pol , S , Degener , F , Postma , M J & Vemer , P 2017 , ' An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands ' , Value in Health , vol. 20 , no. 3 , pp. 388-396 . https://doi.org/10.1016/j.jval.2016.10.015;
2017
3
Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research
van Asselt, Thea, Ramaekers, Bram, Ramos, Isaac Corro, Joore, Manuela, Al, Maiwenn, Lesman-Leegte, Ivonne, Postma, Maarten, Vemer, Pepijn, Feenstra, Talitha
Veröffentlicht in: van Asselt , T , Ramaekers , B , Ramos , I C , Joore , M , Al , M , Lesman-Leegte , I , Postma , M , Vemer , P & Feenstra , T 2018 , ' Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research ' , Pharmacoeconomics , vol. 36 , no. 1 , pp. 105-113 . https://doi.org/10.1007/s40273-017-0572-7;
2018
Veröffentlicht in: van Asselt , T , Ramaekers , B , Ramos , I C , Joore , M , Al , M , Lesman-Leegte , I , Postma , M , Vemer , P & Feenstra , T 2018 , ' Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research ' , Pharmacoeconomics , vol. 36 , no. 1 , pp. 105-113 . https://doi.org/10.1007/s40273-017-0572-7;
2018
4
van Asselt, Thea, Ramaekers, Bram, Corro Ramos, Isaac, Joore, Manuela, Al, Maiwenn, Lesman-Leegte, Ivonne, Postma, Maarten, Vemer, Pepijn, Feenstra, Talitha
Veröffentlicht in: van Asselt , T , Ramaekers , B , Corro Ramos , I , Joore , M , Al , M , Lesman-Leegte , I , Postma , M , Vemer , P & Feenstra , T 2018 , ' Research Costs Investigated : A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research ' , Pharmacoeconomics , vol. 36 , no. 1 , pp. 105-113 . https://doi.org/10.1007/s40273-017-0572-7;
2018
Veröffentlicht in: van Asselt , T , Ramaekers , B , Corro Ramos , I , Joore , M , Al , M , Lesman-Leegte , I , Postma , M , Vemer , P & Feenstra , T 2018 , ' Research Costs Investigated : A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research ' , Pharmacoeconomics , vol. 36 , no. 1 , pp. 105-113 . https://doi.org/10.1007/s40273-017-0572-7;
2018
5
Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands:A systematic review
van Schoonhoven, Alexander V, Gout-Zwart, Judith J, de Vries, Marijke J S, van Asselt, Antoinette D I, Dvortsin, Evgeni, Vemer, Pepijn, van Boven, Job F M, Postma, Maarten J
Veröffentlicht in: van Schoonhoven , A V , Gout-Zwart , J J , de Vries , M J S , van Asselt , A D I , Dvortsin , E , Vemer , P , van Boven , J F M & Postma , M J 2019 , ' Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands : A systematic review ' , PLoS ONE , vol. 14 , no. 9 , e0221856 . https://doi.org/10.1371/journal.pone.0221856;
2019
Veröffentlicht in: van Schoonhoven , A V , Gout-Zwart , J J , de Vries , M J S , van Asselt , A D I , Dvortsin , E , Vemer , P , van Boven , J F M & Postma , M J 2019 , ' Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands : A systematic review ' , PLoS ONE , vol. 14 , no. 9 , e0221856 . https://doi.org/10.1371/journal.pone.0221856;
2019
6
Blommestein, Hedwig M., de Groot, Saskia, Aarts, Mieke J., Vemer, Pepijn, de Vries, Robin, van Abeelen, Annet F. M., Posthuma, E. F. M. Ward, Uyl-de Groota, Carin A.
Veröffentlicht in: Blommestein , H M , de Groot , S , Aarts , M J , Vemer , P , de Vries , R , van Abeelen , A F M , Posthuma , E F M W & Uyl-de Groota , C A 2016 , ' Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands ' , Leukemia Research , vol. 50 , pp. 37-45 . https://doi.org/10.1016/j.leukres.2016.09.005;
2016
Veröffentlicht in: Blommestein , H M , de Groot , S , Aarts , M J , Vemer , P , de Vries , R , van Abeelen , A F M , Posthuma , E F M W & Uyl-de Groota , C A 2016 , ' Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands ' , Leukemia Research , vol. 50 , pp. 37-45 . https://doi.org/10.1016/j.leukres.2016.09.005;
2016
7